MAP3K5 and cerebral infarction: Thus, YZR extract treatments reduce cerebral infarction partially through the downregulation of JNK-mediated TLR4/T3JAM- and ASK1-related inflammatory signaling at 1 day after reperfusion (Fig. 13).